ArticlePediatric cardiology2020

Management of Persistent Pulmonary Hypertension After Correction of Congenital Heart Defect with Autologous Marrow-Derived Mononuclear Stem Cell Injection into the Pulmonary Artery: A Pilot Study.

Hamid Amoozgar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.